Your browser doesn't support javascript.
loading
Quality of economic evaluations of ventricular assist devices: A systematic review.
Fontenay, Sarah; Catarino, Lionel; Snoussi, Soumeya; van den Brink, Hélène; Pineau, Judith; Prognon, Patrice; Martelli, Nicolas.
Afiliación
  • Fontenay S; Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015Paris, France.
  • Catarino L; Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015Paris, France.
  • Snoussi S; Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015Paris, France.
  • van den Brink H; Université Paris-Saclay GRADES, 92290Châtenay-Malabry, France.
  • Pineau J; Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015Paris, France.
  • Prognon P; Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015Paris, France.
  • Martelli N; Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015Paris, France.
Article en En | MEDLINE | ID: mdl-32618521
ABSTRACT

OBJECTIVE:

Because of a lack of suitable heart donors, alternatives to transplantation are required. These alternatives can have high costs. The aim of this study was to perform a systematic review of cost-effectiveness studies of ventricular assist devices (VADs) and to assess the level of evidence of relevant studies. The purpose was not to present economic findings.

METHODS:

A systematic review was performed using four electronic databases to identify health economic evaluation studies dealing with VADs. The methodological quality and reporting quality of the studies was assessed using three different tools, the Drummond, Cooper, and CHEERS (Consolidated Health Economic Evaluation Reporting Standards) checklists.

RESULTS:

Of the 1,258 publications identified, thirteen articles were included in this review. Twelve studies were cost-utility analyses and one was a cost-effectiveness analysis. According to the Cooper hierarchy scale, the quality of the data used was heterogeneous. The level of evidence used for clinical effect sizes, safety data, and baseline clinical data was of poor quality. In contrast, cost data were of high quality in most studies. Quality of reporting varied between studies, with an average score of 17.4 (range 15-19) according to the CHEERS checklist.

CONCLUSION:

The current study shows that the quality of clinical data used in economic evaluations of VADs is rather poor in general. This is a concern that deserves greater attention in the process of health technology assessment of medical devices.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Systematic_reviews Idioma: En Revista: Int J Technol Assess Health Care Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2020 Tipo del documento: Article País de afiliación: Francia Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Systematic_reviews Idioma: En Revista: Int J Technol Assess Health Care Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2020 Tipo del documento: Article País de afiliación: Francia Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM